SP |
2000 |
90 |
7%(6/90) (b) |
NA |
29%(26/90) (e) |
42%(38/90) (e) |
NA |
Mendonça et al.5757. Mendonça S, Ecclissato C, Sartori MS, Godoy AP, Guerzoni RA, Degger M, et al. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil. Helicobacter. 2000;5:79-83.)
|
MG |
2002 |
202 |
9.8%(20/202) (c) |
90.0% (18/20) A2142G/A2143G A2142G: 16.7% (3/18), A2143G: 66.6% (12/18), A2142G +A2143G: 16.7%(3/18) |
NA |
53%(107/202) (e) |
NA |
Magalhães et al.5252. Magalhães PP, Queiroz DM, Barbosa DV, Rocha GA, Mendes EN, Santos A, et al. Helicobacter pylori primary resistance to metronidazole and clarithromycin in Brazil. Antimicrob Agents Chemother. 2002;46:2021-3.
|
SP |
2003 |
52 |
(c) |
94.2% (49/52) A2142G/A2143G A2142G: 87.7%(43/49) A2143G:12.3%(6/49) |
NA |
NA |
NA |
Ribeiro et al.7575. Ribeiro ML, Vitiello L, Miranda MCB, Benvengo YH, Godoy APO, Mendonca S, et al. Mutations in the 23S rRNA gene are associated with clarithromycin resistance in Helicobacter pylori isolates in Brazil. Ann Clin Microbiol Antimicrob. 2003;2:1-4.)
|
SP |
2003 |
138 |
16%(23/138) (c) |
NA |
38%(54/138) (e) |
55%(75/138) (e) |
NA |
Godoy et al.2828. Godoy AP, Ribeiro ML, Benvengo YH, Vitiello L, Miranda Mde C, Mendonca S, et al. Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates. BMC Gastroenterol 2003;3:1-6.)
|
SP |
2008-2009 |
45 |
27%(12/45) (b) |
100%(12/12) A2142G/A2143G A2143G: 67% (8/12) A2142G:33%(4/12) |
4%(2/45) (d) |
13%(6/45) (d) |
NA |
Garcia e al.2626. Garcia GT, Aranda KR, Goncalves ME, Cardoso SR, Iriya K, Silva NP, et al. High prevalence of clarithromycin resistance and cagA, vacA, iceA2, and babA2 genotypes of Helicobacter pylori in Brazilian children. J Clin Microbiol. 2010;48:4266-8.)
|
AM |
2007-2008 |
41 |
NA |
75.6% (31/41) 23S rRNA A2143G (3.3%), T2182C (12.9%), G2224A (6.45%), T2215C (61.3%) A2192G (3.3%), G2204C (6.4%), T2221C (6.4%) |
NA |
NA |
NA |
Barile et al.66. Barile KAS, Silva ALC, Xavier JNX, Assumpção MB, Corvelo TCO. Characterization of 23S rRNA domain V mutations in gastric biopsy patients from the eastern Amazon. Mem Inst Oswaldo Cruz. 2010;105:314-7.)
|
SP |
2011 |
39 |
8%(3/39) (b) |
NA |
0% (0/39) (a) |
51%(20/39) (e) |
23%(9/39) (b) |
Eisig et al.2222. Eisig JN, Silva FM, Barbuti RC, Navarro-Rodriguez T, Moraes-Filho JP, Pedrazzoli Jr J. Helicobacter pylori antibiotic resistance in Brazil: clarithromycin is still a good option. Arq Gastroenterol. 2011;48:261-4.)
|
SP |
2003-2006 |
488 |
NA |
2.5% (12/488) A2143G/A2142G A2142G: 25%(3/12) A2143G:58.3%(7/12) A2143G + A2142G: 8.7% (1/12) |
NA |
NA |
NA |
Suzuki et al.9090. Suzuki RB, Almeida CM, Speranca MA: Absence of Helicobacter pylori high tetracycline resistant 16S rDNA AGA926-928TTC genotype in gastric biopsy specimens from dyspeptic patients of a city in the interior of Sao Paulo, Brazil. BMC Gastroenterol. 2012;12:1-5.)
|
RS |
2011-2012 |
54 |
11.1% (6/54) (b) |
NA |
1.9%(1/54) (b) |
NA |
NA |
Picoli et al.7171. Picoli SU, Mazzoleni LE, Fernández H, DE Bona LR, Neuhauss E, Longo L &Prolla JC. Resistance to amoxicillin, clarithromycin and ciprofloxacin of Helicobacter pylori isolated from southern Brazil patients. Rev. Inst. Med. Trop. Sao Paul. 2014;56:197-200.)
|